(Q37848838)

24 August 2017

1 reference

title

Present and future of influenza prevention in pediatrics (English)

1 reference

24 August 2017

2

1 reference

24 August 2017

1

Nicola Principi

1 reference

24 August 2017

3

Paola Marchisio

1 reference

24 August 2017

language of work or name

English

0 references

publication date

3 March 2011

1 reference

Expert Opinion on Biological Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

641-653

1 reference

The impact of influenza epidemics on hospitalizations.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Influenza and the rates of hospitalization for respiratory disease among infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Socioeconomic impact of influenza on healthy children and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Antivirals for influenza: strategies for use in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

The burden of influenza in children: time for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

The rational use of influenza vaccines in healthy children and children with underlying conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

21 January 2018

Antigen delivery systems

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Improving seasonal and pandemic influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Dissolving polymer microneedle patches for influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Influenza vaccine dosages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Vaccine adjuvants: current state and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

The virosomal adjuvanted influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

The virosome concept for influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Inflexal V--the influenza vaccine with the lowest ovalbumin content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Vaccination, squalene and anti-squalene antibodies: facts or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Continuous cell lines as a production system for influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive c

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Effectiveness of maternal influenza immunization in mothers and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Influenza-Associated Deaths among Children in the United States, 2003–2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.562495

10.1517/14712598.2011.562495

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kf7ujiylzjcbpg4j6mmtokrruu

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_kf7ujiylzjcbpg4j6mmtokrruu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kf7ujiylzjcbpg4j6mmtokrruu

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/kf7ujiylzjcbpg4j6mmtokrruu

1 reference